Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody
- PMID: 6427778
- PMCID: PMC345322
- DOI: 10.1073/pnas.81.12.3864
Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody
Abstract
Previously we have demonstrated that islets of Langerhans treated with donor-specific anti-Ia serum and complement survive when transplanted across the major histocompatibility complex of the mouse. In this study, using immunofluorescence, we demonstrate two morphologically distinct populations of Ia-positive cells scattered within the Ia-negative islet tissue. A large irregularly shaped Ia-positive subset of cells were identified as dendritic cells by using the 33D1 antibody specific for a mouse dendritic cell antigen. The other small, round Ia-positive subset was 33D1 negative. Islets pretreated with anti-dendritic cell antibody and complement prior to transplantation survived in their histoincompatible recipients for greater than 200 days. Rejection of stable islet allografts promptly occurred when transplant recipients were challenged with 1 X 10(5) donor dendritic cells 60 days after transplantation. These results demonstrate an important in vivo role for donor dendritic cells in the stimulation of allograft rejection.
Similar articles
-
Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants.Proc Natl Acad Sci U S A. 1981 Aug;78(8):5156-9. doi: 10.1073/pnas.78.8.5156. Proc Natl Acad Sci U S A. 1981. PMID: 6795629 Free PMC article.
-
Role of intra-islet endothelial cells in islet allo-immunity.Transplantation. 2007 Nov 27;84(10):1316-23. doi: 10.1097/01.tp.0000288192.11396.70. Transplantation. 2007. PMID: 18049117
-
Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: in-vitro and in-vivo effects on islet antigenicity.Horm Metab Res. 1991 Aug;23(8):357-61. doi: 10.1055/s-2007-1003700. Horm Metab Res. 1991. PMID: 1794836
-
Transplantation without immunosuppression.Diabetes. 1982 Aug;31 Suppl 4:11-6. doi: 10.2337/diab.31.4.s11. Diabetes. 1982. PMID: 6819960 Review.
-
The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation.Ann Surg. 1990 Sep;212(3):308-15; discussion 316-7. doi: 10.1097/00000658-199009000-00009. Ann Surg. 1990. PMID: 2204317 Free PMC article. Review.
Cited by
-
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.J Exp Med. 1985 Mar 1;161(3):526-46. doi: 10.1084/jem.161.3.526. J Exp Med. 1985. PMID: 3871837 Free PMC article.
-
Lymphoid dendritic cells.Immunology. 1987 Oct;62(2):161-70. Immunology. 1987. PMID: 3315976 Free PMC article. Review. No abstract available.
-
Two to Tango: Dialogue between Adaptive and Innate Immunity in Type 1 Diabetes.J Diabetes Res. 2020 Jul 30;2020:4106518. doi: 10.1155/2020/4106518. eCollection 2020. J Diabetes Res. 2020. PMID: 32802890 Free PMC article. Review.
-
The in-vitro inhibition of rat alloantigen presentation by immunotoxins--implications for allografting.Clin Exp Immunol. 1989 Apr;76(1):132-7. Clin Exp Immunol. 1989. PMID: 2525436 Free PMC article.
-
Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody.J Exp Med. 1986 Apr 1;163(4):981-97. doi: 10.1084/jem.163.4.981. J Exp Med. 1986. PMID: 3950549 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical